Is wearable electromyography system (Mshorts) a reliable and valid tool for assessing individuals with and without patellofemoral pain?

Deisi Ferrari0 个研究点目标入组 60 人开始时间: 2015年10月1日最近更新: 2020年1月13日

适应症

试验速览

暂无简介。

•A. Participant is willing and able to give informed consent for participation in the study.
•B. Male or Female, aged 18 to 40 years old.
•C. Diagnosed with PFPS: complaining of knee pain for at least 1 month with an insidious start and healthy volunteers with no knee pain
•D. Participants able to perform physical activity such as stair climbing and squat tests.
•E. Able and willing to comply with all study requirements.
•F. Participants with PFPS must present: (1) anterior knee pain during at least 2 of the following activities: kneeling, squatting, climbing stairs, jumping, running, and remaining seated; (2) symptoms for at least 1 month with an insidious start; (3) pain during patellar palpation; (4) pain level up to 3cm on a 10-cm visual analogic scale (VAS) in the previous week; and (5) at least 3 positive clinical signs of the following tests: Clarke’s sign, Waldron, McConnell, Zohler’s sign, Noble compression, Q angle higher than 18 degrees, and patella in the medial or lateral position. The participants need to fulfil all 5 requirements to be allocated to the PFPS group and could not present any signs or symptoms of PFPS or other disease to be allocated to the control group (pain-free).

•A. Pregnancy during the course of the study.
•B. Any other significant disease or disorder which, in the opinion of the Investigator, may either put the participants at risk because of participation in the study, or may influence the result of the study, or the participant’s ability to participate in the study.
•C. Participants are not able to perform the tests and present other condition as patellar tendon or meniscus tears, ligament tears, bilateral knee pain, bursitis, chondral lesions or osteoarthritis, dislocation or patellar subluxation, presence of neurological diseases, or inflammatory processes
•D. Participants who received oral steroids, steroid injections, opiate treatment, acupuncture or physiotherapy during the last 6 months.

发起方

Deisi Ferrari